Download presentation
1
The Management of ED TIA Patients:
WBH Emergency Medicine Residency Grand Rounds May 31, 2007 Michael A. Ross MD FACEP Associate Professor Emergency Medicine Department of Emergency Medicine William Beaumont Hospital Wayne State University School of Medicine
2
Case presentation A 58 year old female presents to the emergency department after developing dysarthria, diploplia, numbness, and pronounced weakness of the right face and hand that lasted roughly 12 minutes. The patient feels completely normal and only came in at her families insistence. Review of systems - mild headache with event. No palpitations, chest pain, or SOB. Past medical history - Positive for hypertension and hyperlipidemia. No prior stroke or TIA. Family history positive for premature coronary disease. Meds - Beta-blocker for HTN. Not on aspirin. Social - She does not smoke.
3
Case presentation Phyisical Exam:
On examination the patient was normotensive, and comfortable. HEENT exam showed no facial or oral asymmetry or numbness. No scalp tenderness. CHEST exam showed no murmurs and a regular rhythm, ABDOMINAL and EXTREMITY exam was normal, NEUROLOGICAL exam showed normal mentation, CN II-XII normal as tested, motor / sensory exam normal, symmetrical normal reflexes, and normal cerebellar exam.
4
Case presentation ED course:
ECG showed a normal sinus rhythm with mild LVH. Non-contrast head CT scan was normal. Blood-work (CBC with differential, electrolytes, BUN/Cr, and glucose) was normal. ESR was normal. Monitor showed no dysrhythmias Normal subsequent neurological symptoms. The patient feels fine and is wondering if she can go home. What do you think?
5
Background 300,000 TIAs occur annually - Johnstons’ data
Within 90 days: 10.5% will suffer a stroke 21% will be fatal 64% will be disabling Half of these will occur within days of ED visit 2.6% will die 2.6% will suffer adverse cardiovascular events 12.7% will have additional TIAs
6
Stroke Risk After TIA Year N Stroke Risk
Johnston, et al (Kaiser ED) % /90d Eliasew, et al (NASCET) % /90d Lovett, et al (Oxfordshire) % /30d Gladstone, et al (Toronto) % /30d Daffertshofer, et al (Grmy) % /180d Hill, et al (Alberta) % /90d Lisabeth, et al (Texas) % /90d Kleindorfer, et al (Cinc) % /90d Whitehead, et al (Scotland) % /30d Correia, et al (Portugal) % /7d Tsivgoulis, et al (Greece) % /30d AVERAGE ~12% stroke risk in 90 days after TIA 5% in first 2 days
7
Stroke Risk After Stroke
IST 3.3 %/ 3m CAST 1.6%/ 3m TOAST 5.7%/ 3m NASCET 2.3%/3m AVERAGE ~4% stroke risk in 90 days after stroke
8
Pathophysiology Short-term risk of stroke: Possible explanation
After TIA (11%) > after stroke (4%) Possible explanation Tissue still at risk: unstable situation More thrombo-embolic events Johnston, NEJM 2002; 347:1687
9
Candidate Blood Markers???
Unstable plaque with intense staining for PAPP-A within spindle shaped smooth muscle cells and in extracellular matrix of eroded plaque Stable plaque with absence of PAPP-A staining Unstable plaque ; Lp-PLA2 Candidate Blood Markers??? Unstable Plaque: Lp-PLA2, PAPP-A, MMP-9, CRP, S-TF Coagulation Activation: D-dimer, F 1.2, TAT Cardioembolism: BNP (CHF), D-dimer
10
TIA: Differential Diagnosis “Mimics”
Cervical disc disease Carpal tunnel syndrome Metabolic derangement (ex, hypoglycemia) Inner ear disease/BPV Transient global amnesia Cranial arteritis Epilepsy Complicated migraine Subdural hematoma Mass lesions, AVMs Arterial dissection Oxfordshire Community Stroke Project found that 62% of patients referred by GP with a diagnosis of TIA were found to have some other explanation for symptoms (Dennis M, Stroke 1989)
11
Is a “TIA” a TIA? Little agreement, even among neurologists (kappa ) Generally, neurologists are not the ones making the diagnosis May even be less reproducibility Risk factors for stroke may identify true TIAs Johnston et al, Neurology 2003; 60:280
12
Utility of the H/P? TIA risk stratification Johnston criteria
Rothwell criteria - “ABCD” Combination of the above = “ABCD2”
13
Risk factors were additive
TIA risk stratification - California Model Johnston et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284: Independent risk factors for stroke: Age > 60yr (OR = 1.8) Diabetes (OR = 2.0) TIA > 10 min. (OR = 2.3) Weakness with TIA (OR = 1.9) Speech impairment (OR = 1.5) Risk factors were additive
14
Our patient’s Johnston score?
Independent risk factors for stroke: Age > 60yr Diabetes TIA > 10 min Weakness with TIA Speech impairment 1 stroke risk score of 3: ~5% at one week ~8% at 3 months
15
TIA risk stratification - British model. Rothwell,et al
TIA risk stratification - British model? Rothwell,et al. Lancet 2005; 366: 29–36 A = Age >60 years = 1pt B = BP: SBP >140 or DBP >90 = 1pt C = Clinical: Unilateral weakness = 2pt Speech disturbance = 1pt D = Duration >60 min = 2pt 10 – 59 min = 1pt <10 min = 0pt
17
Our patients ABCD score?
A = Age >60 years = 0 B = BP: SBP >140 or DBP >90 = 0 C = Clinical: Unilateral weakness = 2pt Speech disturbance = 1pt D = Duration >60 min = 0 10 – 59 min = 1pt <10 min = 0 TOTAL SCORE = 4 (5% risk of stroke at one week)
18
ABCD2 Score
19
ABCD2 Score Score points for each of the following: Final Score 0-7
Age >60 (1) Blood pressure >140/90 on initial evaluation (1) Clinical: Focal weakness (2) Speech impairment without weakness (1) Duration >60 min (2) 10-59 min (1) Diabetes (1) Final Score 0-7
20
ABCD2 Score Validation: Meta-analysis
21
ABCD2 Score and Stroke Risks
22
Prognosis Conclusions
The ABCD2 Score stratifies short-term risk of stroke after TIA 2-day risks Low Risk (34%): Score 0-3 1% Moderate Risk (45%): Score 4-5 4% Very High Risk (21%): Score 6-7 8% “This rule is ready for clinical use” C. Johnston
23
What is our patients’ ABCD2 score?
Age > = 0 Blood pressure >140/90 (initial) (1) = 0 Clinical: Focal weakness (2) = 2 Speech impairment without weakness (1) = 0 Duration >60 min (2) = 0 10-59 min (1) = 1 Diabetes (1) = 0 Total = 3 Stroke at 2 days = 1% Stroke at 7 days = 2% (?!)
24
Limitations of Prediction Rules
Discriminatory value sub-optimal What about the patient with 90% carotid stenosis and a low score??? Generalizability seems poor (though exact reasons for this unclear) Are these rules really just selecting patients with “real” TIAs?
25
2. HCT, ECG HCT - tumor, SDH, NPH, etc
Minor stroke and TIA associated with a 10% incidence of stroke on MRI.
26
Infarction in TIA Approximately 50% of those with TIA have DWI changes on MRI Kidwell et al Stroke 1999
27
TIA Stroke Reversible ischemia Infarction Minor stroke DWI+ TIA
Reversible ischemic neurologic deficit (RIND) Stroke Cerebral infarction with transient signs
28
2. HCT, ECG ECG – ATRIAL FIBRILLATION!!!
Stroke risk – cardio-embolic risk 4.6% at 1 month 11.9% at 3 months 61% reduction in annual risk of stroke (both ischemic or hemorrhagic) with coumadin
29
3. Carotid Dopplers Stroke risk depends on where the disease is:
7day 90day CE = Cardio-Embolic: 2.5% 12% LAA = Large arteries 4.0% 19% Und = Undetermined 2.3% 9% SVS = Small Vessels 0% 3%
30
Outpatient carotid dopplers?
Office management of TIA??? Goldstein et al. New transient ischemic attack and stroke: outpatient management by primary care physicians. Arch Intern Med. 2000;160: Design: Retrospective study of 95 TIA and 81 stroke patients seen in office Diagnostic testing within 30 days: 23% had head CT done 40% had carotid dopplers done 18% had ECG done 19% had echo done 31% had no other evaluation
31
5. Medical management Antiplatelet Therapy
Useful in non-cardioembolic causes Aspirin mg/day Clopidogrel or ticlopidine Aspirin plus dipyridamole Latter two if ASA intolerant or if TIA while on ASA Routine anticoagulation not recommended
32
5. Medical management Risk Factor Management
HTN: BP below 140/90 DM: fasting glucose < 126 mg/dl Hyperlipidemia: LDL < 100 mg/dl Stop smoking! Exercise min, 3x/week Avoid excessive alcohol use Weight loss: < 120% of ideal weight
33
Hospital Admission for TIA
Medical management to minimize risk of recurrent ischemia Expedite evaluation and treatment of specific mechanisms – CEA for carotid stenosis, anticoagulation for atrial fibrillation Observation for further events, with potential expedited thrombolysis Avoid the lawyers
34
Management of TIA: Areas of Certainty:
Need for ED visit, ECG, labs, Head CT Areas of less certainty The timing of the carotid dopplers Areas of Uncertainty - Johnston SC. N Engl J Med. 2002;347: “The benefit of hospitalization is unknown. . . Observation units within the ED may provide a more cost-effective option.”
35
An Emergency Department Diagnostic Protocol For Patients With Transient Ischemic Attack: A Randomized Controlled Trial To determine if emergency department TIA patients managed using an accelerated diagnostic protocol (ADP) in an observation unit (EDOU) will experience: shorter length of stays lower costs comparable clinical outcomes . . . relative to traditional inpatient admission.
36
Patient population: ED evaluation:
Presented to the ED with symptoms of TIA ED evaluation: History and physical ECG, monitor, HCT Appropriate labs Diagnosis of TIA established Decision to admit or observe SCREENING AND RANDOMIZATION
37
Methods: ADP Interventions
Four components: Serial neuro exams Unit staff, physician, and a neurology consult Cardiac monitoring Carotid dopplers 2-D echo BOTH study groups had orders for the same four components
38
Methods: ADP Disposition criteria
Home No recurrent deficits, negative workup Appropriate antiplatelet therapy and follow-up Inpatient admission from EDOU Recurrent symptoms or neuro deficit Surgical carotid stenosis (ie >50%) Embolic source requiring treatment Unable to safely discharge patient
39
Results: Performance of clinical testing
40
Results: Length of Stay
Median Inpatient = 61.2 hr ADP = 25.6 hr Difference = 29.8 hr (Hodges-Lehmann) (p<0.001) ADP sub-groups: ADP - home = 24.2 hr ADP - admit = hr
41
Results: 90-Day Clinical Outcomes
42
Results: 90 - day Costs Median Inpatient = $1548 ADP = $890
Difference = $540 (Hodges-Lehmann) (p<0.001) ADP sub-groups: ADP - home = $844 ADP - admit = $2,737
43
Study conclusion: Compared to inpatient admission, the ED TIA diagnostic protocol was: More efficient Less costly With comparable clinical outcomes
44
Implications National feasibility of ADP: 18% of EDs have an EDOU
220 JCAHO stroke centers National health care costs Potential savings if 18% used ADP: $29.1 million dollars Medicare observation APC Impact of shorter LOS Patients – satisfaction, missed Dx . . . Hospitals – bed availability
45
CLINICAL CASE - OUTCOME
The patient was started on aspirin and admitted to the ED observation unit. While in the unit she had a 2-D echo with bubble contrast, that was normal. She had no arrhythmia detected on cardiac monitoring and no subsequent neurological deficits. However, carotid dopplers were abnormal. She showed 30-50% stenosis of the right internal carotid artery, and a severe flow limiting >70% stenosis of the left carotid artery at the origin of the internal carotid artery. She was admitted to the hospital for endarterectomy. Five days following ED arrival, and following inpatient pre-operative clearance, she underwent successful endarterectomy. On one month follow-up she was asymptomatic and her carotids were doing well.
46
Who do you send home from the ED???
C. Johnston: “TIA risk score does not identify a “zero” risk group” But it is a good start. . . Possibly: Negative ED work-up (ECG, exam, CT), low TIA score, negative carotid dopplers within 6 months, safe home support for return in next 48 hours if needed? Appropriate medications.
47
Who do you send home from the ED???
Ron Krome: “It doesn’t matter what you do, as long as you are right” If you are not sure, better play it safe. . . Admit or observe
48
Conclusions TIAs are ominous
Justifies acute interventions, including hospitalization Opportunity to prevent injury but trials are needed Recovery rather than complete resolution is likely the important distinguishing characteristic and may identify an unstable pathophysiology “TIAs” are heterogeneous Management should be individualized Prognostic scores may help Secondary prevention is critical ferne_aaem_2008_lecture_Ross_Bunney_072208_final 4/19/2017 2:05 AM
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.